Binder Biomedical

About:

Binder Biomedical develops and supplies medical devices for the treatment of orthopedic and neurological spinal disorders.

Website: http://binderspine.com/

Twitter/X: BinderSpine

Description:

Binder Biomedical, Inc. develops and supplies medical devices for the treatment of complex orthopedic and neurological spinal disorders. Its product portfolio focuses on applications for spine fusion surgery, including biologics. The company offers NEWTON Intervertebral Body Fusion System, a line of lumbar interbody spacers that include lumbar intervertebral body, anterior lumbar interbody, posterior lumbar intervertebral body, and transforaminal lumbar intervertebral body fusion devices. It also provides X-GRAFT, an interspinous allograft/donated human tissue; and cervical spacer, anterior lumbar spacer, and posterior lumbar spacer allografts designed to treat degenerative conditions of the spine. In addition, the company offers specialized implants that enable the maximization of disc height restoration and sufficient structural support while conforming to the anatomical requirements of the patient. It serves surgeons through sales agents and representatives in the United States and internationally. The company was founded in 2009 and is based in Boca Raton, Florida with an operations office in Miami, Florida.

Total Funding Amount:

$685000

Estimated Revenue Range:

Less than $1M

Headquarters Location:

Miami, Florida, United States

Founded Date:

2009-01-01

Contact Email:

info(AT)bindermed.com

Founders:

Number of Employees:

1-10

Last Funding Date:

2012-04-26

IPO Status:

Private

Industries:

© 2025 bioDAO.ai